Dai-ichi Life Insurance Company’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.38M | Buy |
7,033
+1,836
| +35% | +$357K | 0.04% | 300 |
|
|
2025
Q4 | $902K | Hold |
5,197
| – | – | 0.02% | 389 |
|
|
2025
Q3 | $990K | Hold |
5,197
| – | – | 0.02% | 361 |
|
|
2025
Q2 | $934K | Sell |
5,197
-4,793
| -48% | -$833K | 0.03% | 369 |
|
|
2025
Q1 | $1.69M | Hold |
9,990
| – | – | 0.05% | 288 |
|
|
2024
Q4 | $1.51M | Sell |
9,990
-294
| -3% | -$45.7K | 0.04% | 324 |
|
|
2024
Q3 | $1.6M | Hold |
10,284
| – | – | 0.04% | 317 |
|
|
2024
Q2 | $1.41M | Hold |
10,284
| – | – | 0.03% | 327 |
|
|
2024
Q1 | $1.37M | Hold |
10,284
| – | – | 0.03% | 344 |
|
|
2023
Q4 | $1.42M | Sell |
10,284
-402
| -4% | -$52.9K | 0.03% | 336 |
|
|
2023
Q3 | $1.3M | Hold |
10,686
| – | – | 0.03% | 341 |
|
|
2023
Q2 | $1.5M | Hold |
10,686
| – | – | 0.03% | 328 |
|
|
2023
Q1 | $1.51M | Sell |
10,686
-10,000
| -48% | -$1.43M | 0.03% | 329 |
|
|
2022
Q4 | $3.24M | Hold |
20,686
| – | – | 0.07% | 228 |
|
|
2022
Q3 | $2.54M | Hold |
20,686
| – | – | 0.06% | 249 |
|
|
2022
Q2 | $2.75M | Hold |
20,686
| – | – | 0.06% | 246 |
|
|
2022
Q1 | $2.83M | Sell |
20,686
-10,000
| -33% | -$1.39M | 0.05% | 296 |
|
|
2021
Q4 | $5.31M | Hold |
30,686
| – | – | 0.07% | 213 |
|
|
2021
Q3 | $4.46M | Hold |
30,686
| – | – | 0.06% | 227 |
|
|
2021
Q2 | $4.05M | Hold |
30,686
| – | – | 0.05% | 245 |
|
|
2021
Q1 | $3.94M | Hold |
30,686
| – | – | 0.05% | 236 |
|
|
2020
Q4 | $3.66M | Buy |
30,686
+9,200
| +43% | +$1.12M | 0.05% | 234 |
|
|
2020
Q3 | $2.46M | Hold |
21,486
| – | – | 0.04% | 280 |
|
|
2020
Q2 | $2.45M | Sell |
21,486
-475
| -2% | -$50.4K | 0.06% | 254 |
|
|
2020
Q1 | $1.76M | Hold |
21,961
| – | – | 0.07% | 279 |
|
|
2019
Q4 | $2.35M | Hold |
21,961
| – | – | 0.05% | 307 |
|
|
2019
Q3 | $2.35M | Hold |
21,961
| – | – | 0.06% | 304 |
|
|
2019
Q2 | $2.24M | Hold |
21,961
| – | – | 0.05% | 316 |
|
|
2019
Q1 | $1.98M | Buy |
+21,961
| New | +$1.9M | 0.05% | 335 |
|
|
2018
Q2 | – | Sell |
-2,244
| Closed | -$225K | – | 519 |
|
|
2018
Q1 | $225K | Hold |
2,244
| – | – | ﹤0.01% | 489 |
|
|
2017
Q4 | $221K | Sell |
2,244
-75,658
| -97% | -$7.17M | ﹤0.01% | 487 |
|
|
2017
Q3 | $7.29M | Hold |
77,902
| – | – | 0.15% | 127 |
|
|
2017
Q2 | $8.66M | Buy |
77,902
+6,140
| +9% | +$649K | 0.19% | 109 |
|
|
2017
Q1 | $7.05M | Buy |
71,762
+11,393
| +19% | +$1.09M | 0.19% | 130 |
|
|
2016
Q4 | $5.55M | Buy |
+60,369
| New | +$5.2M | 0.16% | 153 |
|
Other funds holding DGX
VCM
VPM
EIG
Dai-ichi Life Insurance Company's DGX Position: Q1 2026 in Review
Dai-ichi Life Insurance Company increased its Quest Diagnostics (DGX) stake by 35% in Q1 2026, buying an estimated $357K and bringing the position to 7,033 shares worth $1.38M. The position accounts for 0.04% of the portfolio, ranked #300.
Dai-ichi Life Insurance Company first reported a position in DGX in Q4 2016 and has held it in 35 quarters since. The position peaked at $8.66M in Q2 2017. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Dai-ichi Life Insurance Company held 7,033 shares of Quest Diagnostics worth $1.38M as of Q1 2026.
- Dai-ichi Life Insurance Company bought 1,836 Quest Diagnostics shares in Q1 2026, an estimated $357K.
- Quest Diagnostics made up 0.04% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #300 holding.
- Dai-ichi Life Insurance Company first reported a position in Quest Diagnostics in Q4 2016 and has held it in 35 quarters since.
- Dai-ichi Life Insurance Company's Quest Diagnostics position peaked at $8.66M in Q2 2017.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.